Cargando…
Novel Lipid-Lowering Agents Proprotein Convertase Subtilisin-Kexin Type 9 Inhibitors: Do They Show Mortality Benefits?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082012/ https://www.ncbi.nlm.nih.gov/pubmed/30123740 http://dx.doi.org/10.4103/ijabmr.IJABMR_217_18 |